Trending Topic

4 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

Welcome to the latest edition of touchREVIEWS in Respiratory & Pulmonary Diseases. As we continually strive to deliver cutting-edge research and insightful commentary, this issue is no exception, featuring a diverse array of articles that illuminate both emerging treatments and evolving practices within the field of respiratory and pulmonary medicine. We begin with a compelling […]

7 mins

Mario Cazzola, CHEST 2022: Bronchodilator Interactions with Therapeutics for COPD Comorbidities

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Jul 22nd 2022

COPD is associated with multiple comorbidities such as cardiovascular diseases, depression, and diabetes mellitus. Bronchodilators are often used in the management of COPD, but can also have an effect on comorbidities. We caught up with editorial board member Professor Mario Cazzola (University of Rome ‘Tor Vergata’, Rome, Italy) to discuss bronchodilator selection in patients with COPD and the importance of minimising the risk of drug interactions.

‘What’s New in COPD Pharmacology’ was presented at CHEST Congress 2022, 27-29 June 2022.

Questions

  1. What are the potential interactions between bronchodilators and drugs used to treat comorbidities? (0:42)
  2. What questions should be asked when selecting bronchodilators for COPD? (5:19)

Disclosures: Mario Cazzola has nothing to disclose in relation to this video interview.

Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Victoria Jones.

Filmed in coverage of the CHEST meeting 2022.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied

This Functionality is for
Members Only

Explore the latest in medical education and stay current in your field. Create a free account to track your learning.

Close Popup